Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-31falseHolding company2023-01-01false64falsefalse 12124727 2023-01-01 2023-12-31 12124727 2022-01-01 2022-12-31 12124727 2023-12-31 12124727 2022-12-31 12124727 2022-01-01 12124727 c:Director1 2023-01-01 2023-12-31 12124727 c:Director1 2023-12-31 12124727 c:Director2 2023-01-01 2023-12-31 12124727 c:Director3 2023-01-01 2023-12-31 12124727 c:Director4 2023-01-01 2023-12-31 12124727 c:Director4 2023-12-31 12124727 c:Director5 2023-01-01 2023-12-31 12124727 c:Director5 2023-12-31 12124727 c:Director6 2023-01-01 2023-12-31 12124727 c:Director6 2023-12-31 12124727 c:Director7 2023-01-01 2023-12-31 12124727 c:Director7 2023-12-31 12124727 c:RegisteredOffice 2023-01-01 2023-12-31 12124727 c:Agent1 2023-01-01 2023-12-31 12124727 d:PlantMachinery 2023-01-01 2023-12-31 12124727 d:PlantMachinery 2023-12-31 12124727 d:PlantMachinery 2022-12-31 12124727 d:PlantMachinery d:OwnedOrFreeholdAssets 2023-01-01 2023-12-31 12124727 d:CurrentFinancialInstruments 2023-12-31 12124727 d:CurrentFinancialInstruments 2022-12-31 12124727 d:Non-currentFinancialInstruments 2023-12-31 12124727 d:Non-currentFinancialInstruments 2022-12-31 12124727 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 12124727 d:CurrentFinancialInstruments d:WithinOneYear 2022-12-31 12124727 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 12124727 d:Non-currentFinancialInstruments d:AfterOneYear 2022-12-31 12124727 d:UKTax 2023-01-01 2023-12-31 12124727 d:UKTax 2022-01-01 2022-12-31 12124727 d:ShareCapital 2023-01-01 2023-12-31 12124727 d:ShareCapital 2023-12-31 12124727 d:ShareCapital 2022-01-01 2022-12-31 12124727 d:ShareCapital 2022-12-31 12124727 d:ShareCapital 2022-01-01 12124727 d:SharePremium 2023-01-01 2023-12-31 12124727 d:SharePremium 2023-12-31 12124727 d:SharePremium 2022-01-01 2022-12-31 12124727 d:SharePremium 2022-12-31 12124727 d:SharePremium 2022-01-01 12124727 d:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 12124727 d:RetainedEarningsAccumulatedLosses 2023-12-31 12124727 d:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 12124727 d:RetainedEarningsAccumulatedLosses 2022-12-31 12124727 d:RetainedEarningsAccumulatedLosses 2022-01-01 12124727 c:OrdinaryShareClass1 2023-01-01 2023-12-31 12124727 c:OrdinaryShareClass1 2023-12-31 12124727 c:OrdinaryShareClass1 2022-12-31 12124727 c:OrdinaryShareClass2 2023-01-01 2023-12-31 12124727 c:OrdinaryShareClass2 2023-12-31 12124727 c:OrdinaryShareClass2 2022-12-31 12124727 c:FRS102 2023-01-01 2023-12-31 12124727 c:Audited 2023-01-01 2023-12-31 12124727 c:FullAccounts 2023-01-01 2023-12-31 12124727 c:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 12124727 d:Subsidiary1 2023-01-01 2023-12-31 12124727 d:Subsidiary1 1 2023-01-01 2023-12-31 12124727 d:Subsidiary2 2023-01-01 2023-12-31 12124727 d:Subsidiary2 1 2023-01-01 2023-12-31 12124727 d:Subsidiary3 2023-01-01 2023-12-31 12124727 d:Subsidiary3 1 2023-01-01 2023-12-31 12124727 6 2023-01-01 2023-12-31 12124727 e:PoundSterling 2023-01-01 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 12124727










AML JURATEK LIMITED










ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

 
AML JURATEK LIMITED
 
 
COMPANY INFORMATION


Directors
T J Whewell 
M Clegg 
A Incerti (appointed 1 March 2023)
H Fernando De Souza (appointed 1 March 2023)
A Pontalti (appointed 1 March 2023)




Registered number
12124727



Registered office
Unit 3 Rockingham Way
Redhouse Interchange

Doncaster

South Yorkshire

DN6 7FB




Independent auditors
Shorts
Chartered Accountants & Statutory Auditor

2 Ashgate Road

Chesterfield

Derbyshire

S40 4AA




Bankers
HSBC Bank plc





 
AML JURATEK LIMITED
 

CONTENTS



Page
Strategic Report
 
1 - 2
Directors' Report
 
3 - 4
Independent Auditors' Report
 
5 - 8
Statement of Comprehensive Income
 
9
Balance Sheet
 
10
Statement of Changes in Equity
 
11
Notes to the Financial Statements
 
12 - 19


 
AML JURATEK LIMITED
 
 
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2023

Introduction
 
The directors present their strategic report for the year ended 31 December 2023.

Business review
 
AML Juratek Limited doesn't perform any function other than that of a holding company. The directors have therefore included the Strategic Report of the main trading company, Juratek Limited.
During the year the company was acquired by Fras-Le BV.
The directors report that the market in which the business operates remains competitive in the current economic climate, impacting on the margins achieved on many product line and pre-tax profitability

Principal risks and uncertainties
 
Sales and Profit risk - the Company operates in a competitive market but retains a good market share and continues to out perform some of it rivals. The Company's aim is to continue growing its turnover by introducing new products and adding to existing ranges whilst promoting the Juratek's own brand.
Credit Risk - where the Company extends credit to its customers it insures against the possibility of the debt not being paid, mitigating the impact of potential bad debts.
Liquidity Risk - the directors control and monitor the cash flow of the Company on a regular basis.
Foreign Exchange Rate Risk - the Company is not immune to changes in the global economic environment and subsequent fluctuations in foreign exchange rates. The directors reduce foreign exchange rate risk to an acceptably low level using forward currency contracts, which fix the exchange rate on goods purchased and therefore maintain a consistent gross profit margin.
Employees - In order to meet its objective it is essential that the Company recruits and retains the higher calibre of employees at every level of the organisation. The employment policies of the Company embody the principles of equal opportunity. The Company gives full and fair consideration to employment for disabled persons. If an employee became disabled, arrangements would be made wherever practicable by identifying employment suited to that person's capabilities and provided necessary retraining.

Financial key performance indicators
 
The company's key performance indicators for the year are as follows:
Turnover - £23,859,560 (2022 £21,118,959)
Gross profit - £9,238,235 (2022: £8,523,285)
Gross margin - 38.7% (2022: 40.4%)
Profit before tax - £2,807,473 (2022: £907,344)
Future developments and future strategy 
The company continues to operate a sales strategy based on providing new model ranges and increasing and improving existing model ranges. The company continues to review and improve the performance of its products to ensure they remain one of the leading suppliers in the market. The company continues to look to increase its geographical market share by trading in a large number of countries.

Page 1

 
AML JURATEK LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023


This report was approved by the board on 2 August 2024 and signed on its behalf.



M Clegg
Director

Page 2

 
AML JURATEK LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2023

The directors present their report and the financial statements for the year ended 31 December 2023.

Directors' responsibilities statement

The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The loss for the year, after taxation, amounted to £2,871,125 (2022 - profit £479,403).

Directors

The directors who served during the year were:

M S Robinson (resigned 29 February 2024)
T J Whewell 
M Clegg 
N E Robinson (resigned 1 March 2023)
A Incerti (appointed 1 March 2023)
H Fernando De Souza (appointed 1 March 2023)
A Pontalti (appointed 1 March 2023)

Qualifying third party indemnity provisions

The directors have been granted a qualifying third party indemnity provision under Section 234 of the Companies Act 2006. This indemnity does not provide cover in the event of a director being proven to have acted fraudulently or dishonestly.

Page 3

 
AML JURATEK LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2023

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' Report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditors are unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Post balance sheet events

There have been no factors affecting the company since the year end.

Auditors

The auditorsShortswill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board on 2 August 2024 and signed on its behalf.
 





M Clegg
Director

Page 4

 
AML JURATEK LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AML JURATEK LIMITED
 

Opinion


We have audited the financial statements of AML Juratek Limited (the 'Company') for the year ended 31 December 2023, which comprise the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Company's affairs as at 31 December 2023 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Page 5

 
AML JURATEK LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AML JURATEK LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' Responsibilities Statement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.


Page 6

 
AML JURATEK LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AML JURATEK LIMITED (CONTINUED)


Auditors' responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
through discussions with the directors and other management and from our commercial knowledge and experience of the clients business, we identified the laws and regulations applicable to the Company; and
focusing on the specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the Company, we assessed the extent of compliance with those laws and regulations identified above through making enquiries of management and inspecting relevant correspondence.

We assessed the susceptibility of the Company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and
considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulation.

To address the risk of fraud through management bias and override of controls, we

performed analytical procedures to identify any unusual or unexpected relationships;
reviewed journal entries to identify unusual transactions;
assessed whether judgements and assumptions made in determining the accounting estimates;
were indicative of potential bias; and
investigated the rationale behind significant or unusual transactions.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

agreeing financial statement disclosures to underlying supporting documentation;
reading the minutes of meetings of those charged with governance;
enquiring of management as to actual and potential litigation and claims; and
reviewing and correspondence with HMRC, relevant regulators and the Company’s legal advisors.

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations
Page 7

 
AML JURATEK LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AML JURATEK LIMITED (CONTINUED)


to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any 

Material misstatements that arise due to fraud can be harder to detect than those that arise from error astheymay involve deliberate concealment or collusion.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' Report.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Andrew Irvine (Senior Statutory Auditor)
  
for and on behalf of
Shorts
 
Chartered Accountants
Statutory Auditor
  
2 Ashgate Road
Chesterfield
Derbyshire
S40 4AA

2 August 2024
Page 8

 
AML JURATEK LIMITED
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2023

2023
2022
Note
£
£

  

Administrative expenses
  
(31,392)
(100,923)

Other operating income
 3 
100,000
100,000

Operating profit/(loss)
  
68,608
(923)

Income from shares in group undertakings
  
1,273,345
527,500

Amounts written off investments
  
(4,176,882)
-

Interest payable and similar expenses
 7 
(26,047)
(47,174)

(Loss)/profit before tax
  
(2,860,976)
479,403

Tax on (loss)/profit
  
(10,149)
-

(Loss)/profit for the financial year
  
(2,871,125)
479,403

The notes on pages 12 to 19 form part of these financial statements.

Page 9

 
AML JURATEK LIMITED
REGISTERED NUMBER: 12124727

BALANCE SHEET
AS AT 31 DECEMBER 2023

2023
2022
Note
£
£

Fixed assets
  

Tangible assets
 9 
781
921

Investments
 10 
3,165,474
4,436,317

  
3,166,255
4,437,238

Current assets
  

Debtors: amounts falling due within one year
 11 
263
1,730,416

Cash at bank and in hand
  
114
12,850

  
377
1,743,266

Creditors: amounts falling due within one year
 12 
(4,495,076)
(4,310,887)

Net current liabilities
  
 
 
(4,494,699)
 
 
(2,567,621)

Total assets less current liabilities
  
(1,328,444)
1,869,617

Creditors: amounts falling due after more than one year
 13 
-
(326,936)

  

Net (liabilities)/assets
  
(1,328,444)
1,542,681


Capital and reserves
  

Called up share capital 
 14 
200
200

Share premium account
 15 
-
1,568,715

Profit and loss account
 15 
(1,328,644)
(26,234)

  
(1,328,444)
1,542,681


The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 August 2024.




M Clegg
Director

The notes on pages 12 to 19 form part of these financial statements.

Page 10

 
AML JURATEK LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2023


Called up share capital
Share premium account
Profit and loss account
Total equity

£
£
£
£


At 1 January 2022
200
1,568,715
21,863
1,590,778


Comprehensive income for the year

Profit for the year
-
-
479,403
479,403
Total comprehensive income for the year
-
-
479,403
479,403


Contributions by and distributions to owners

Dividends: Equity capital
-
-
(527,500)
(527,500)


Total transactions with owners
-
-
(527,500)
(527,500)



At 1 January 2023
200
1,568,715
(26,234)
1,542,681


Comprehensive income for the year

Loss for the year
-
-
(2,871,125)
(2,871,125)
Total comprehensive income for the year
-
-
(2,871,125)
(2,871,125)

Transfer to/from profit and loss account
-
(1,568,715)
1,568,715
-


Total transactions with owners
-
(1,568,715)
1,568,715
-


At 31 December 2023
200
-
(1,328,644)
(1,328,444)


The notes on pages 12 to 19 form part of these financial statements.

Page 11

 
AML JURATEK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1.


General information

AML Juratek Limited is a company limited by shares, incorporated in England and Wales (registered number: 12124727). Its registered office is Unit 3, Rockingham Way, Redhouse Interchange, Doncaster, South Yorkshire, DN6 7FB. During the year the Company's princial activity remained that of a holding company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies.

The company, being a member of a group which prepares publicly available consolidated financial statements, has taken advantage of the exemption granted in FRS 102 not to present cash flow statement and certain information about financial instruments.
The company is exempt from the requirement to prepare group accounts in accordance with S401 of the Companies Act 2006, as the company itself is a subsidiary undertaking and the company and all of its subsidiary undertakings are included in the consolidated financial statements of its ultimate parent company Fras-Le, a company incorporated in Brazil. These financial statements have been filed with Companies House along with the accounts of the ultimate UK parent company, AML Juratek Limited. 
The Company's functional and presentational currency is pounds sterling.

The following principal accounting policies have been applied:

 
2.2

Taxation

Tax is recognised in the Statement of Comprehensive Income.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.
Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Page 12

 
AML JURATEK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.3

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Plant and machinery
-
15%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.4

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 13

 
AML JURATEK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.8

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Other operating income

2023
2022
£
£

Other operating income
100,000
100,000



4.


Auditors' remuneration

During the year, the Company obtained the following services from the Company's auditors:


2023
2022
£
£

Fees payable to the Company's auditors for the audit of the Company's financial statements
4,275
6,600

Page 14

 
AML JURATEK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

5.


Employees

Staff costs, including directors' remuneration, were as follows:


2023
2022
£
£

Wages and salaries
9,860
59,160

Social security costs
763
3,169

Cost of defined contribution scheme
4,047
21,084

14,670
83,413


The average monthly number of employees, including the directors, during the year was as follows:


        2023
        2022
            No.
            No.







Directors
6
4


6.


Directors' remuneration

2023
2022
£
£

Directors' emoluments
9,860
59,160

Company contributions to defined contribution pension schemes
4,047
21,084

13,907
80,244


During the year retirement benefits were accruing to 2 directors (2022 - 2) in respect of defined contribution pension schemes.


7.


Interest payable and similar expenses

2023
2022
£
£


Bank interest payable
26,047
47,174

Page 15

 
AML JURATEK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

8.


Taxation


2023
2022
£
£

Corporation tax


Current tax on profits for the year
10,149
-


Total current tax
10,149
-

Deferred tax

Total deferred tax
-
-


Tax on (loss)/profit
10,149
-

Factors affecting tax charge for the year

The tax assessed for the year is lower than (2022 - lower than) the standard rate of corporation tax in the UK of 23.52% (2022 - 19%). The differences are explained below:

2023
2022
£
£


(Loss)/profit on ordinary activities before tax
(2,860,976)
479,403


(Loss)/profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 23.52% (2022 - 19%)
(672,917)
91,087

Effects of:


Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
982,531
72

Non-taxable income
(299,498)
(100,225)

Movement in deferred tax not recognised
33
30

Group relief
-
9,036

Total tax charge for the year
10,149
-

Page 16

 
AML JURATEK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

9.


Tangible fixed assets





Plant and machinery

£



Cost


At 1 January 2023
1,317



At 31 December 2023

1,317



Depreciation


At 1 January 2023
396


Charge for the year on owned assets
140



At 31 December 2023

536



Net book value



At 31 December 2023
781



At 31 December 2022
921


10.


Fixed asset investments





Investments in subsidiary companies

£



Cost


At 1 January 2023
4,436,317


Additions
2,906,039


Disposals
(4,176,882)



At 31 December 2023
3,165,474




Page 17

 
AML JURATEK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Class of shares

Holding

Tekjur Limited
Ordinary
100%
Juratek Limited
Ordinary
100%
Bettaparts
Ordinary
100%

The aggregate of the share capital and reserves as at 31 December 2023 and the profit or loss for the year ended on that date for the subsidiary undertakings were as follows:

Name
Aggregate of share capital and reserves
Profit/(Loss)
£
£

Tekjur Limited
100
823,121

Juratek Limited
7,366,615
2,127,659

Bettaparts
1,145,853
634,711


11.


Debtors

2023
2022
£
£


Amounts owed by group undertakings
-
1,632,694

Other debtors
263
97,722

263
1,730,416



12.


Creditors: Amounts falling due within one year

2023
2022
£
£

Bank loans
-
421,152

Trade creditors
990
986

Amounts owed to group undertakings
4,477,864
3,882,149

Corporation tax
10,149
-

Other taxation and social security
4,549
5,077

Other creditors
1,524
1,523

4,495,076
4,310,887


Page 18

 
AML JURATEK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

13.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Bank loans
-
326,936



14.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



160 (2022 - 160) Ordinary A shares shares of £1.00 each
160
160
40 (2022 - 40) Ordinary B shares shares of £1.00 each
40
40

200

200



15.


Reserves

Share premium account

The share premium account represents the amount above nominal value received for shares sold, less transaction costs.

Profit and loss account

Profit and loss account represents all current and prior period retained profits and losses and is all considered to be distributable.


16.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £4,047 (2022 - £21,084).


17.


Related party transactions

Included in other debtors is an amount of £nil (2022: £97,304) due to the directors.

18.


Controlling party

On 1 March 2023 the entire share capital of AML Juratek Limited was sold to Fras-Le, a company incorporated in Brazil. The company's controlling entity is Fras-Le, Avenida Rubem Bento Alves, No 1469, Room 6, Bairro Interlagos.

 
Page 19